Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su M Metcalfe

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 11, 2009
The E3 ligase axotrophin/MARCH-7: protein expression profiling of human tissues reveals links to adult stem cellsCristina A Szigyarto, Paul Sibbons, Gill Williams, et al.
Transplantation|March 24, 2005
Leukemia inhibitory factor is linked to regulatory transplantation toleranceSu M Metcalfe, Tracy J Watson, Sandra Shurey, et al.
Transplantation|August 19, 2007
Regulatory transplantation tolerance and "stemness": evidence that Foxp3 may play a regulatory role in SOCS-3 gene transcriptionPoorni Muthukumarana, Wook-Jin Chae, Stephen Maher, et al.
Cell Cycle (Georgetown, Tex.)|April 4, 2009
Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6Wenda Gao, Lorraine Thompson, Qiang Zhou, et al.
FEBS Letters|January 27, 2005
Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune toleranceSu M Metcalfe, Poorni A De S Muthukumarana, H Lorraine Thompson, et al.
Cell Cycle (Georgetown, Tex.)|October 22, 2010
A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptorLorraine H Thompson, Roy A Whiston, Yerzhan Rakhimov, et al.
Frontiers in Medical Technology|January 20, 2022
Multiple Sclerosis: LIFNano-CD4 for Trojan Horse Delivery of the Neuro-Protective Biologic "LIF" Into the Brain: Preclinical Proof of ConceptRaul de la Flor, Janette Robertson, Rostislav V Shevchenko, et al.
Disease Models & Mechanisms|August 3, 2014
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's diseaseJing-Wei Zhao, Sean C Dyson, Christina Kriegel, et al.
Plos One|December 11, 2012
Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient miceHuansheng Dong, Tarek M Fahmy, Su M Metcalfe, et al.
International Immunopharmacology|December 13, 2006
Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerancePoorni A D S Muthukumarana, Gary E Lyons, Yuji Miura, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 11, 2009
The E3 ligase axotrophin/MARCH-7: protein expression profiling of human tissues reveals links to adult stem cellsCristina A Szigyarto, Paul Sibbons, Gill Williams, et al.
Transplantation|March 24, 2005
Leukemia inhibitory factor is linked to regulatory transplantation toleranceSu M Metcalfe, Tracy J Watson, Sandra Shurey, et al.
Transplantation|August 19, 2007
Regulatory transplantation tolerance and "stemness": evidence that Foxp3 may play a regulatory role in SOCS-3 gene transcriptionPoorni Muthukumarana, Wook-Jin Chae, Stephen Maher, et al.
Cell Cycle (Georgetown, Tex.)|April 4, 2009
Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6Wenda Gao, Lorraine Thompson, Qiang Zhou, et al.
FEBS Letters|January 27, 2005
Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune toleranceSu M Metcalfe, Poorni A De S Muthukumarana, H Lorraine Thompson, et al.
Cell Cycle (Georgetown, Tex.)|October 22, 2010
A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptorLorraine H Thompson, Roy A Whiston, Yerzhan Rakhimov, et al.
Frontiers in Medical Technology|January 20, 2022
Multiple Sclerosis: LIFNano-CD4 for Trojan Horse Delivery of the Neuro-Protective Biologic "LIF" Into the Brain: Preclinical Proof of ConceptRaul de la Flor, Janette Robertson, Rostislav V Shevchenko, et al.
Disease Models & Mechanisms|August 3, 2014
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's diseaseJing-Wei Zhao, Sean C Dyson, Christina Kriegel, et al.
Plos One|December 11, 2012
Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient miceHuansheng Dong, Tarek M Fahmy, Su M Metcalfe, et al.
International Immunopharmacology|December 13, 2006
Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerancePoorni A D S Muthukumarana, Gary E Lyons, Yuji Miura, et al.
Pageof 2